Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Photo of Matt De Silva
Individual Investor

Matt De Silva

Overview

Edit Overview Section
Number of Portfolio Companies 3
Number of Current Board & Advisor Roles 1
  • Primary Job Title Chief Operating Officer
  • Primary Organization 
    Pathos Logo
    Pathos
  • Investor Type 
    obfuscation
Matt De Silva is the Chief Operating Officer at Pathos. He was the CEO at Notable Labs

Personal Investments

Edit Personal Investments Section
Number of Investments 3
Matt De Silva has made 3 investments. Their latest investment was Seed Round - Eigen Therapeutics on
obfuscation
, when Eigen Therapeutics raised
obfuscation
.
Announced Date  
Organization Name  
Lead Investor  
Funding Round  
Money Raised  
obfuscation
Eigen Therapeutics Logo
Eigen Therapeutics
—
Seed Round - Eigen Therapeutics Logo
Seed Round - Eigen Therapeutics
obfuscation
obfuscation
Arpeggio Bio Logo
Arpeggio Bio
—
Series A - Arpeggio Bio Logo
Series A - Arpeggio Bio
obfuscation
obfuscation
Enveda Biosciences Logo
Enveda Biosciences
—
Series A - Enveda Biosciences Logo
Series A - Enveda Biosciences
obfuscation

Jobs

Edit Jobs Section
Number of Current Jobs 4
Number of Past Jobs 1
Matt De Silva has 4 current jobs including Founder & Executive Chairman at Notable Labs, Analyst at Bank of America, and Venture Partner at Builders VC. Additionally, Matt De Silva has had 1 past job as the Founder & CEO at Notable Labs.
Organization Name  
Title At Company  
Start Date  
End Date  
Notable Labs Logo
Notable Labs
Founder & CEOMay 2014—

Board and Advisor Roles

Edit Board and Advisor Roles Section
Number of Current Board & Advisor Roles 1
Matt De Silva is the Advisor and Angel Investor at Endpoint Health.

Related Hubs

Edit Related Hubs Section
Hub Name  
CB Rank (Hub)  
Echo Global Logistics Alumni Founded Companies Logo
Echo Global Logistics Alumni Founded Companies
93,924
Biotechnology Late Stage Companies With Fewer Than 1000 Employees Logo
Biotechnology Late Stage Companies With Fewer Than 1000 Employees
42,779
Life Science Companies (Top 10K) Logo
Life Science Companies (Top 10K)
3,221
Medical Companies With Fewer Than 100 Employees (Top 10K) Logo
Medical Companies With Fewer Than 100 Employees (Top 10K)
1,902
Data Management Companies With Fewer Than 1000 Employees Logo
Data Management Companies With Fewer Than 1000 Employees
4,091
Medical Late Stage Companies With More Than 10 Employees Logo
Medical Late Stage Companies With More Than 10 Employees
30,933
Medical Late Stage Companies With Fewer Than 1000 Employees Logo
Medical Late Stage Companies With Fewer Than 1000 Employees
31,646
Medical Unicorn Startups Logo
Medical Unicorn Startups
70,040
Artificial Intelligence (AI) Late Stage Companies With Fewer Than 1000 Employees Logo
Artificial Intelligence (AI) Late Stage Companies With Fewer Than 1000 Employees
13,930
Data Management Companies With Fewer Than 100 Employees Logo
Data Management Companies With Fewer Than 100 Employees
4,603

Education

Edit Education Section
Matt De Silva studied at Cornell University and  Purdue University Daniels School of Business.

Recent News and Activity

Edit Recent News and Activity Section
Funding Round•Dec 8, 2022
Eigen Therapeutics raised
obfuscation
from Alumni Ventures and 11 other investors
Discover more funding rounds
Funding Round•Sep 7, 2022
Arpeggio Bio raised
obfuscation
from Alice Zhang and 11 other investors
Discover more funding rounds
Funding Round•Jun 22, 2021
Enveda Biosciences raised
obfuscation
from Bioverge and 10 other investors
Discover more funding rounds
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(ccb7a32 1)
|